AI-powered drug discovery: is it the next frontier of medicine? From cutting down costs, to speeding up development, the technology promises plenty – but can it deliver? In this episode, Bloomberg’s Tom Mackenzie speaks exclusively to Demis Hassabis, the Nobel Laureate aiming to literally “solve all disease” through his work at London-based Isomorphic Labs. Hassabis’ work comes in addition to his responsibilities at Alphabet Inc., where he oversees all of the company’s core AI work as co-founder and CEO of Google DeepMind.
—
“Bloomberg Tech: Europe” spotlights the biggest names and trends shaping the region’s technology ecosystem as the global competition heats up. This monthly, 30-minute magazine-style show features in-depth interviews with top technology leaders, as well as major investors and policymakers – giving you a compelling A to Z of the most consequential innovations, opportunities and challenges.
Chapters:
00:01:06 – Bloomberg Tech: Europe
00:01:16 – Isomorphic Labs Working To ‘Solve All Disease’
00:02:03 – Demis Hassabis, Isomorphic Labs Founder & CEO
00:11:51 – Max Jaderberg, Isomorphic Labs Chief AI Officer
00:15:53 – Rebecca Paul, Isomorphic Labs Medicinal Drug Design Head
00:19:51 – Mihaela van der Schaar, University of Cambridge
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:
Get the latest in tech from Silicon Valley and around the world here:
Connect with us on…
X:
Facebook:
Instagram:
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
Listen to the daily Bloomberg Technology podcast here:
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:
source
